Search PubMed⌕ Search

Biomedical subjects

P Jenoure

Publications and source records attributed to P Jenoure.

15 recordsLinked to original sources
PubMed2000

Changes in hemoglobin values in elite cross-country skiers from 1987-1999.

Hemoglobin data have been available from ski teams beginning from 1987, and from 1989 to 1999 we have followed hemoglobin values in elite cross-country skiers in international competitions. The mean values at the 1989 World Nordic Ski Championships were lower than population reference values, as would be expected from plasma volume expansion associated with endurance training. However, an increase, particularly in the maximal values, became obvious in 1994 and rose further in 1996. These extreme values provide both a health risk to the individual athlete and unfair competition. After a rule limiting hemoglobin values was introduced, the drop of the highest values was remarkable: among men 15 g/l (0.23 mmol/l) and among women 42 g/l (0.65 mmol/l). It would appear that the rule had achieved its goal of limiting extreme hemoglobin values. Yet the mean hemoglobin concentrations in men and women have continued to rise, suggesting the continued use of artificial methods to increase total hemoglobin mass.

Acclimatization↗
PubMed1993

[Rehabilitation after cruciate ligament repair with the middle third of the patellar ligament in the athlete].

Rehabilitation of athletes following surgical reconstruction of complex instabilities of the knee joint focuses on four goals: 1. the restoration of ligament stability, 2. the restoration of muscular stabilisation ability, 3. the restoration of coordinative muscular function in sport specific kinesiology, 4. the retention and improvement of the general state of fitness. These aims can only be reached by a close cooperation between physician, physiotherapist, trainer, and coach. In order not to put the rehabilitation process at risk, everybody involved has to have knowledge about functional anatomy, surgical technique, and biology of the transplant as well as knowledge about the long duration thereof that cannot substantially be shortened by knee ortheses. No athlete should compete until he has demonstrated sufficient fitness, strength, and coordination for his sport under laboratory conditions.

Anterior Cruciate Ligament↗
PubMed1993

A trial with diclofenac HEP plaster as topical treatment in minor sport injuries.

Diclofenac HEP plaster was tested in an open study in the treatment of different traumatic sport and overload injuries, to confirm the results of efficacy and tolerability already shown in other clinical studies. A total of 101 patients were assigned to treatment and were eligible for the evaluation of results at the end of a 14-day treatment period. The average score of spontaneous pain, assessed by means of a verbal scale and a visual analogical scale, showed a clear difference in pain rating between the beginning and end of treatment. In general 60% pain reduction was observed. The difference in analgesic activity was already apparent on the 7th day of treatment (-28%). The reduction of pain was confirmed by changes in another subjective sign related to the injury: provoked pain. This symptom decreased in a manner comparable to spontaneous pain: 61% pain reduction after 2 weeks of treatment. Global assessment of efficacy, performed by the investigator at the end of treatment, showed the clear therapeutic activity of local treatment with diclofenac HEP plaster. Satisfactory results were obtained and only 18% of the patients (most of them with chronic and persistent pain) experienced ineffective pain relief at the end of the 2-week treatment. The beneficial effects of diclofenac HEP plaster on pain are confirmed by the patients' assessment, since almost identical scores were obtained. It is striking that the overall tolerance of diclofenac HEP plaster, applied topically twice a day for 2 weeks, was "good" or "excellent" in the 101 patients treated. Any side effect was reported on the patient's card and all the patients completed the study.

Administration, Cutaneous↗
PubMed1990

[The incidence of hay fever in leading Swiss athletes].

This enquiry covers 2961 active Swiss athletes of national or international standing in 68 different sports. Of these, 2060 (70%; 1507 males, 552 females) answered the questionnaire. 347 athletes (16.8%) indicated they suffered from hay fever, 204 of them (59%) needing medication during the pollen season. 25% took antihistamines, 20% various nasal decongestants, 19% Similasan, a homeopathic drug, and 11% various eye drops. 6% received injections of depot corticosteroid preparations. 50% of the athletes obtained these medications on prescription. 146 athletes (7.1%) complained of lower respiratory tract symptoms, 77 of them mentioning asthma attacks and 47 continuous dyspnea. The enquiry shows that the incidence of hay fever in highly trained athletes is as high as in the general Swiss population. The same is true of asthma. A considerable proportion of allergic athletes are inadequately informed as to both antiallergic therapy and doping regulations.

Adolescent↗